| Catalog_no |
ADMC0709 |
| Product_name |
PF06463922(Lorlatinib) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1000.00/2660.00/4660.00 |
| Specificity |
Target: ALK. Fields: PF06463922 is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity. Ki: < 0.02 nM (ROS1), < 0.07 nM |
| Dilution |
Ki: < 0.02 nM (ROS1), < 0.07 nM (ALK WT), 0.7 nM (ALK L1196M) |
| Purification |
>99% |
| Concentration |
靶点：ALK;IC50：Ki: < 0.02 nM (ROS1), < 0.07 nM (ALK WT), 0.7 nM (ALK L1196M) |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
PF06463922,PF-06463922,PF 06463922 |
| Molecular Weight |
406.1 |
| Notes |
PF06463922 is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1), with potential antineoplastic activity. Ki: < 0.02 nM (ROS1), < 0.07 nM (ALK WT), 0.7 nM (ALK |
| Instructions |
 查看与下载 |
